4//SEC Filing
David Itamar 4
Accession 0001165527-10-000600
CIK 0001424860other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:46 PM ET
Size
9.3 KB
Accession
0001165527-10-000600
Insider Transaction Report
Form 4
David Itamar
Chief Financial Officer
Transactions
- Purchase
Common Stock
2010-08-12$2.00/sh+25,000$50,000→ 525,483 total - Purchase
Warrant
2010-08-12+12,500→ 12,500 totalExercise: $4.00From: 2010-08-12Exp: 2012-08-12→ Commom Stock (12,500 underlying) - Purchase
Common Stock
2010-07-15$0.30/sh+201,122$60,337→ 500,483 total
Footnotes (4)
- [F1]Reporting Person disclaims beneficial ownership of shares owned by his spouse, Hadas David.
- [F2]Purchase agreement includes a one year adjusting pre-emption provision to increase number of shares of holder upon payment of par value, at Reporting Person's election if Company sells shares at less than purchase price.
- [F3]Exercise price subject to downward formula adjustment if Company sells or commits to sell shares at less than $2.00 during the one year after issuance of Warrant.
- [F4]Exercise period subject to extension equal to expiration date of any different class of warrants sold by company during the one year after issuance of Warrant.
Documents
Issuer
Enox Biopharma Inc
CIK 0001424860
Entity typeother
Related Parties
1- filerCIK 0001454396
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:46 PM ET
- Size
- 9.3 KB